Alessandro Limongelli

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

Jon Salmanton‐García, Francesco Marchesi, Francesca Farina et al. · EClinicalMedicine · 2024 · 32 citations · Full text

Medicine, Infectious Diseases, Epidemiology +6

Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring

Małgorzata Mikulska, Monica Melchio, Alessio Signori et al. · Journal of Antimicrobial Chemotherapy · 2024 · 26 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +17

Impact of Fluconazole Resistance on the Outcomes of Patients With <i>Candida parapsilosis</i> Bloodstream Infections: A Retrospective Multicenter Study

Antonio Vena, Giusy Tiseo, Marco Falcone et al. · Clinical Infectious Diseases · 2025 · 22 citations

Life Sciences, Infectious Diseases, Microbiology +16

Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodies

Margherita Bellucci, Federica Bozzano, Chiara Castellano et al. · Frontiers in Immunology · 2024 · 20 citations · Full text

Medicine, Infectious Diseases, Neurology +16

Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry

Jon Salmanton‐García, Francesco Marchesi, Philipp Koehler et al. · International Journal of Antimicrobial Agents · 2023 · 17 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17